XBiotech (XBIT) Return on Assets [ROA] (2015 - 2026)
XBiotech (XBIT) recorded Return on Assets [ROA] of -29.17% in Q2 2026, down 13.55 percentage points from -15.62% a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, XBiotech reported Return on Assets [ROA] of -26.08%, down 7.98 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of -24.17 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -18.10% in FY2024 (-7.71 pp), -10.39% in FY2023 (+2.23 pp), -12.62% in FY2022 (-7.09 pp) and -5.54% in FY2021 (-3.62 pp).
- The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] since Q3 2019.
- On a year-over-year basis, Return on Assets [ROA] rose in 1 of the last seven quarters, with an average year-over-year change of -6.37 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 4.00 percentage points in Q3 2023, against a drop of 194.19 percentage points in Q3 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | XBiotech | 66.77 Mn | 66.77 Mn | - | -29.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.17% |
| Dec 31, 2025 | -28.24% |
| Sep 30, 2025 | -16.61% |
| Jun 30, 2025 | -15.62% |
| Mar 31, 2025 | -20.69% |
| Dec 31, 2024 | -18.84% |
| Sep 30, 2024 | -15.35% |
| Jun 30, 2024 | -15.79% |
| Mar 31, 2024 | -13.53% |
| Dec 31, 2023 | -10.80% |
| Sep 30, 2023 | -9.98% |
| Jun 30, 2023 | -11.94% |
| Mar 31, 2023 | -12.86% |
| Dec 31, 2022 | -13.24% |
| Sep 30, 2022 | -13.98% |
| Jun 30, 2022 | -9.96% |
| Mar 31, 2022 | -7.41% |
| Dec 31, 2021 | -6.28% |
| Sep 30, 2021 | -4.04% |
| Jun 30, 2021 | -3.39% |
API Access
XBiotech Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();